EODData

MEMBERSHIP REGISTER LOG IN

FRA, AB3A: Sarepta Therapeutics Inc

03 Jul 2026
LAST:

16.84

CHANGE:
 1.04		OPEN:
16.84		HIGH:
16.84		ASK:
0.00		VOLUME:
1.1K
CHG(%):
6.58		PREV:
15.80		LOW:
16.84		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
03 Jul 2616.8416.8416.8416.841.1K
02 Jul 2615.8015.8015.8015.80434
30 Jun 2614.8814.8814.8814.880
29 Jun 2614.5014.5014.3814.38130
25 Jun 2614.8014.8414.8014.8450
24 Jun 2615.1415.1415.1415.140
23 Jun 2615.1215.1215.1215.120
22 Jun 2615.0615.0615.0615.060
19 Jun 2615.0215.0215.0215.022.8K
18 Jun 2614.7414.7414.7414.740

PROFILE

Name:Sarepta Therapeutics Inc
About:Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat Duchenne muscular dystrophy (Duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an adeno-associated virus based gene therapy for the treatment of ambulatory pediatric patients with Duchenne with a confirmed mutation in the Duchenne gene. The company is also developing SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Catalent Maryland, Inc.; Nationwide Children's Hospital; Dyno Therapeutics; Hansa Biopharma; Duke University; and Genethon. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:215 First Street, Cambridge, MA, United States, 02142
Website:https://www.sarepta.com
ISIN:US8036071004
LEI:549300IKDPIED8J8IG21

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:26.97 
Forward P/E:-3.10 
PEG Ratio:-3.10 
Price to Sales:0.80 
Price to Book:1.66 
Profit Margin:-0.11 
Operating Margin:-0.16 
Return on Assets:-0.02 
Return on Equity:-0.21 
Revenue:2.048B 
EBITDA:275.54M 
Shares:104.67M 
Market Cap:1.763B 

TECHNICAL INDICATORS

MA5:15.359.7%
MA10:15.1810.9%
MA20:14.3417.4%
MA50:15.449.1%
MA100:15.786.7%
MA200:16.651.1%
STO9:100.00 
STO14:100.00 
RSI14:82.70 
MTM14:4.02
ROC14:0.31 
ATR:0.42 
Week High:16.840.0%
Week Low:14.3817.1%
Month High:16.840.0%
Month Low:12.821.1%
Year High:21.4527.4%
Year Low:8.9488.4%
Volatility:3.05 

RECENT SPLITS

Date Ratio
12 Jul 20121-6